Federal appeals court rejects NIH research funding cuts
Source: SeekingAlpha
2026-01-06 07:16:59 ET
More on Thermo Fisher Scientific, Danaher, etc.
- Thermo Fisher: Refinding Some Momentum
- Danaher: Biotech Strength And Cash Generation Reinforce A $250 Fair Value
- Agilent Technologies, Inc. (A) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
- Thermo Fisher upgraded at Citi on boost in pharma spending
- Waters raised to Outperform at Wolfe on BD Life Sciences deal
Read the full article on Seeking Alpha
For further details see:
Federal appeals court rejects NIH research funding cuts
Bruker Corporation
NASDAQ: BRKR
BRKR Trading
2.59% G/L:
$34.645 Last:
27,990 Volume:
$34 Open:
BRKR Latest News
February 25, 2026 07:00:00 am
Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR
February 24, 2026 07:00:00 am
Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic Applications
BRKR Stock Data
$6,342,783,056
108,941,800
0.01%
138
N/A
Biotechnology & Life Sciences
Healthcare
US
Billerica
